The company aims to research, develop, license and market medical therapies, in particular antibody-based therapies against neurological diseases, cancer and immune system disorders. The company may enter into any business and conclude contracts that are suitable to promote the purpose of the company or that are directly or indirectly related to it. The company may establish branches and subsidiaries in Switzerland and abroad, participate in or merge with other companies, as well as acquire and sell real estate in Switzerland and abroad.